Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis
Abstract Trimethylamine-N-oxide (TMAO) is a gut microbiome-derived metabolite of choline, L-carnitine and lecithin, abundant in animal source foods. In experimental models, higher blood TMAO levels enhance atherosclerotic cardiovascular disease (ASCVD). However in humans, most prior studies have eva...
Saved in:
| Main Authors: | Matthew J. Budoff, Marcia C. de Oliveira Otto, Xinmin S. Li, Yujin Lee, Meng Wang, Heidi T. M. Lai, Rozenn N. Lemaitre, Alan Pratt, Wai Hong Wilson Tang, Bruce M. Psaty, David S. Siscovick, Stanley L. Hazen, Dariush Mozaffarian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-05903-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TMAO metaorganismal pathway and chronic inflammatory diseases
by: Zeneng Wang, et al.
Published: (2025-06-01) -
Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health
by: Eugenio Caradonna, et al.
Published: (2025-03-01) -
Trimethylamine-N-oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body
by: Ylenia Heinrich-Sanchez, et al.
Published: (2025-12-01) -
Trimethylamine N-oxide generation process was influenced by the proportion and source of macronutrients in the diet
by: Chengcheng Wang, et al.
Published: (2024-03-01) -
Associations of first-trimester TMAO and its precursors with gestational diabetes mellitus: a pilot prospective cohort study
by: Geng-Dong Chen, et al.
Published: (2025-06-01)